Physician profile
Carrie P Frame
NPI 1992904270
$99,011.77
in general payments reported to CMS, 2019-2025
22 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $6,525 · 2022: $16K · 2023: $8,912 · 2024: $17K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Consulting Fee: $19K · Food and Beverage: $5,233 · Travel and Lodging: $4,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,040.00 |
| Consulting Fee | $19,200.00 |
| Food and Beverage | $5,232.90 |
| Travel and Lodging | $4,068.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $94,540.41 | 2019-2025 | Affinity, Novachor, Puraply Wound Matrix |
| Mid-Atlantic Surgical Systems, LLC | $1,545.23 | 2019-2025 | |
| Arthrex, INC. | $807.15 | 2019-2025 | |
| Amgen INC. | $409.59 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $355.32 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Pico 7 |
| Paratek Pharmaceuticals, INC. | $264.13 | 2019-2025 | Nuzyra |
| Tactile Systems Technology INC | $184.53 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Vaporox, INC. | $142.64 | 2024 | Vht-200 Wound Treatment System |
| Abbvie INC. | $101.19 | 2021-2025 | |
| Melinta Therapeutics, LLC | $100.25 | 2019-2023 | Rezzayo, Orbactiv, Kimyrsa |
| Comsort, INC | $100.00 | 2019 | |
| Integra Lifesciences Corporation | $95.59 | 2020-2021 | |
| Bioventus LLC | $91.88 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $61.20 | 2019-2023 | Krystexxa |
| Angiodynamics, INC. | $52.73 | 2024 | Auryon Laser System 100-120 Vac |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $32.14 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Solventum Corporation | $28.76 | 2024 | Activ.A.C. |
| La Jolla Pharmaceutical Company | $26.08 | 2024 | Xerava |
| Vertex Pharmaceuticals Incorporated | $23.77 | 2025 | |
| Djo, LLC | $23.44 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.92 | 2019 | |
| Grt US Holding, INC. | $5.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.